Transactivation of epidermal growth factor receptor by enhanced levels of endogenous angiotensin II contributes to the overexpression of Giα proteins in vascular smooth muscle cells from SHR

Cellular Signalling

Volumn 23, Issue 11, 2011, Pages 1716-1726

  Sandoval, Yessica Haydee Gomez ^a   Li, Yuan ^a   Anand Srivastava, Madhu B ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Angiotensin II; Epidermal growth factor receptor; Gi protein; Oxidative Stress; SHR; VSMC

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ACETYLCYSTEINE; ADENYLATE CYCLASE; ANGIOTENSIN I; ANGIOTENSIN II; CAPTOPRIL; EPIDERMAL GROWTH FACTOR RECEPTOR; FORSKOLIN; GI ALPHA 2 PROTEIN; GI ALPHA 3 PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); HORMONE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; LOSARTAN; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SMOOTH MUSCLE FIBER; SPONTANEOUSLY HYPERTENSIVE RAT; STRAIN DIFFERENCE; TRANSACTIVATION; VASCULAR SMOOTH MUSCLE CELL; WISTAR KYOTO RAT;

ACETYLCYSTEINE; ADENYLATE CYCLASE; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; FORSKOLIN; GENE EXPRESSION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; HYPERTENSION; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION;

RATTUS;

EID: 80051472452     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2011.06.006     Document Type: Article

References (54)

1. Amer M.S. Life Sci. 1975, 17:1021-1038.
2. Neer E.J. Cell 1995, 80:249-257.
3. Bray P., Carter A., Simons C., Guo V., Puckett C., Kamholz J., Spiegel A., Nirenberg M. Proc. Natl. Acad. Sci. U S A. 1986, 83:8893-8897.
4. Itoh H., Toyama R., Kozasa T., Tsukamoto T., Matsuoka M., Kaziro Y. J. Biol. Chem. 1988, 263:6656-6664.
5. Yatani A., Mattera R., Codina J., Graf R., Okabe K., Padrell E., Iyengar R., Brown A.M., Birnbaumer L. Nature 1988, 336:680-682.
6. Katz A.M., Tada M., Kirchberger M.A. Adv. Cyclic. Nucleotide Res. 1975, 5:453-472.
7. Triner L., Vulliemoz Y., Verosky M., Habif D.V., Nahas G.G. Life Sci. I. 1972, 11:817-824.
8. Noll T., Hempel A., Piper H.M. Am. J. Physiol. 1996, 271:H1878-H1883.
9. Hempel A., Noll T., Bach C., Piper H.M., Willenbrock R., Hohnel K., Haller H., Luft F.C. Am. J. Physiol. 1998, 275:H1818-H1825.
10. Kinoshita S., Sidhu A., Felder R.A. J. Clin. Invest. 1989, 84:1849-1856.
11. Feraille E., Doucet A. Physiol. Rev. 2001, 81:345-418.
12. Tsuda K., Tsuda S., Nishio I., Goldstein M., Masuyama Y. Eur. J. Pharmacol. 1997, 321:5-11.
13. Anand-Srivastava M.B. Biochem. J. 1992, 288:79-85.
14. Anand-Srivastava M.B., Picard S., Thibault C. Am. J. Hypertens. 1991, 4:840-843.
15. Anand-Srivastava M.B., de Champlain J., Thibault C. Am. J. Hypertens. 1993, 6:72-75.
16. Bohm M., Gierschik P., Knorr A., Larisch K., Weismann K., Erdmann E. Hypertension 1992, 20:103-112.
17. Thibault C., Anand-Srivastava M.B. FEBS Lett. 1992, 313:160-164.
18. Anand-Srivastava M.B. Biochem. Pharmacol. 1988, 37:3017-3022.
19. Di Fusco F., Anand-Srivastava M.B. J. Hypertens. 2000, 18:1081-1090.
20. Di Fusco F., Hashim S., Anand-Srivastava M.B. Am. J. Physiol. Cell Physiol. 2000, 279:C990-C998.
21. Li Y., Anand-Srivastava M.B. Circ. Res. 2002, 91:247-254.
22. Marcil J., de Champlain J., Anand-Srivastava M.B. Cardiovasc. Res. 1998, 39:492-505.
23. Pandey S.K., Anand-Srivastava M.B. Am. J. Hypertens. 1996, 9:833-837.
24. Skeggs L.T., Lentz K.E., Kahn J.R., Shumway N.P., Woods K.R. J. Exp. Med. 1956, 104:193-197.
25. Kaschina E., Unger T. Blood Press. 2003, 12:70-88.
26. Du J., Sperling L.S., Marrero M.B., Phillips L., Delafontaine P. Biochem. Biophys. Res. Commun. 1996, 218:934-939.
27. Eguchi S., Numaguchi K., Iwasaki H., Matsumoto T., Yamakawa T., Utsunomiya H., Motley E.D., Kawakatsu H., Owada K.M., Hirata Y., Marumo F., Inagami T. J. Biol. Chem. 1998, 273:8890-8896.
28. Heeneman S., Haendeler J., Saito Y., Ishida M., Berk B.C. J. Biol. Chem. 2000, 275:15926-15932.
29. Daub H., Weiss F.U., Wallasch C., Ullrich A. Nature 1996, 379:557-560.
30. Catt K.J., Cain M.D., Zimmet P.Z., Cran E. British medical journal. 1969, 1:819-821.
31. Sarzani R., Arnaldi G., Chobanian A.V. Hypertension 1991, 17:888-895.
32. Fukuda N., Satoh C., Hu W.Y., Soma M., Kubo A., Kishioka H., Watanabe Y., Izumi Y., Kanmatsuse K. Arterioscler. Thromb. Vasc. Biol. 1999, 19:1210-1217.
33. Lappas G., Daou G.B., Anand-Srivastava M.B. J. Hypertens. 2005, 23:2251-2261.
34. Boumati M., Li Y., Anand-Srivastava M.B. Arch. Biochem. Biophys. 2002, 401:178-186.
35. Palaparti A., Ge C., Anand-Srivastava M.B. Arch. Biochem. Biophys. 1999, 365:113-122.
36. Boumati M., Li Y., Anand-Srivastava M.B. Arch. Biochem. Biophys. 2003, 415:193-202.
37. Anand-Srivastava M.B., Franks D.J., Cantin M., Genest J. Biochem. Biophys. Res. Commun. 1982, 108:213-219.
38. Li Y., Levesque L.O., Anand-Srivastava M.B. Am J Physiol Heart Circ Physiol. 2010, 299:H1625-H1632.
39. Clark C.J., Milligan G., McLellan A.R., Connell J.M. Biochim Biophys Acta. 1992, 1136:290-296.
40. Anand-Srivastava M.B., Srivastava A.K., Cantin M. J. Biol. Chem. 1987, 262:4931-4934.
41. Anand-Srivastava M.B. Biochem. Pharmacol. 1989, 38:489-496.
42. Anand-Srivastava M.B. Biochem. Biophys. Res. Commun. 1983, 117:420-428.
43. Migeon J.C., Thomas S.L., Nathanson N.M. J. Biol. Chem. 1995, 270:16070-16074.
44. Gomez Sandoval Y.H., Anand-Srivastava M.B. Cell. Signal. 2011, 23:354-362.
45. Satoh C., Fukuda N., Hu W.Y., Nakayama M., Kishioka H., Kanmatsuse K. J. Cardiovasc. Pharmacol. 2001, 37:108-118.
46. Wang X.Y., Wu K.G., Jin X.Q., Wang H.J. Zhongguo Yao Li Xue Bao. 1998, 19:136-140.
47. Matsusaka T., Ichikawa I. Annu. Rev. Physiol. 1997, 59:395-412.
48. Katovich M.J., Gelband C.H., Reaves P., Wang H.W., Raizada M.K. Am. J. Physiol. 1999, 277:H1260-H1264.
49. Li Y., Bou Daou G., Anand-Srivastava M.B. Can. J. Cardiol. 2005, 21:1556.
50. Gomez Sandoval Y.H., Levesque L.O., Anand-Srivastava M.B. Can. J. Physiol. Pharmacol. 2009, 87:1037-1045.
51. Kagiyama S., Eguchi S., Frank G.D., Inagami T., Zhang Y.C., Phillips M.I. Circulation 2002, 106:909-912.
52. Wetzker R., Bohmer F.D. Nature reviews. 2003, 4:651-657.
53. Ushio-Fukai M., Griendling K.K., Becker P.L., Hilenski L., Halleran S., Alexander R.W. Arterioscler. Thromb. Vasc. Biol. 2001, 21:489-495.
54. Azar Z.M., Mehdi M.Z., Srivastava A.K. Can. J. Physiol. Pharmacol. 2006, 84:777-786.